Extensive preclinical evaluation of lutetium-177-labeled PSMA-specific tracers for prostate cancer radionuclide therapy.

Eur J Nucl Med Mol Imaging · 2021 · PMC8113296 · PMID 33094433

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

Even though a clear trend was observed of DSB induction, no significant difference in the number of DSBs between both tracers or the different timepoints was observed (Fig. 6 b, c).

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.